A 6-year-old with short bowel syndrome (40 cm remaining small bowel) on home parenteral nutrition for 4 years presents with progressive visual impairment and ataxia. Ophthalmologic exam shows retinopathy and ophthalmoplegia. Laboratory studies show vitamin E 2.1 mg/L (normal 5-18), normal vitamin A and D levels, PT/INR normal, and lipid profile shows total cholesterol 85 mg/dL. The family reports excellent compliance with prescribed fat-soluble vitamin supplementation in the parenteral formula. Synthesize the most likely explanation for isolated vitamin E deficiency.
Q2
A 15-month-old presents with severe protein-energy malnutrition, hepatomegaly, edema, and skin changes (hypopigmentation with desquamation). Total protein 3.8 g/dL, albumin 1.9 g/dL, prealbumin 8 mg/dL. The parents want rapid nutritional rehabilitation, but the physician is concerned about complications. The child also has watery diarrhea and suspected concurrent infection. Evaluate the optimal initial refeeding strategy considering all risk factors.
Q3
A 14-year-old girl with anorexia nervosa is admitted for refeeding. Her BMI is 13.5 kg/m². Initial laboratory studies show sodium 136 mEq/L, potassium 3.3 mEq/L, phosphorus 3.8 mg/dL, magnesium 1.9 mg/dL. On day 3 of refeeding (advancing from 800 to 1400 kcal/day), she develops confusion, weakness, and respiratory distress. Repeat labs show phosphorus 1.1 mg/dL, potassium 2.8 mEq/L, and magnesium 1.2 mg/dL. ECG shows QTc prolongation. Evaluate the pathophysiology and priority management.
Q4
A 7-month-old infant presents with developmental regression, irritability, and poor feeding. He was born to consanguineous parents and has been on a special metabolic formula since birth due to an inborn error of metabolism. Examination shows hypotonia, megaloblastic anemia (MCV 115 fL), and homocystinuria without methylmalonic aciduria. Plasma homocysteine is markedly elevated while methionine is low. Analyze the most likely enzymatic defect.
Q5
A 2-year-old girl presents with bowing of legs, rachitic rosary, and delayed dentition. Radiographs show metaphyseal widening and cupping. Laboratory studies reveal calcium 8.5 mg/dL, phosphorus 2.1 mg/dL, PTH 95 pg/mL, alkaline phosphatase 850 U/L, and 25-hydroxyvitamin D 8 ng/mL. Her 4-year-old sibling has similar findings but with normal 25-hydroxyvitamin D levels and elevated 1,25-dihydroxyvitamin D. Analyze the most likely diagnosis in the sibling.
Q6
A 5-year-old boy presents with night blindness and multiple respiratory infections over the past 6 months. He has a history of chronic pancreatitis secondary to cystic fibrosis. Physical examination reveals conjunctival xerosis and Bitot spots. Serum retinol level is 15 μg/dL (normal 30-80). Despite adequate pancreatic enzyme replacement, symptoms persist. Analyze the underlying mechanism and most likely additional deficiency.
Q7
A 9-month-old infant presents with failure to thrive, chronic diarrhea, and a periorificial dermatitis. The mother reports the infant has been on a strict elimination diet due to suspected food allergies. Physical examination reveals alopecia, angular cheilitis, and vesiculobullous rash around the mouth, genitals, and extremities. Serum zinc level is 35 μg/dL (normal 60-120). Apply the appropriate management.
Q8
A 4-month-old infant presents with tetany and seizures. Parents report exclusive breastfeeding with recent switch to homemade formula made from evaporated milk. Physical examination shows hyperreflexia and positive Chvostek sign. Laboratory studies reveal calcium 6.8 mg/dL, phosphorus 8.2 mg/dL, and PTH 180 pg/mL. ECG shows prolonged QT interval. Apply the immediate management.
Q9
A 3-year-old boy presents with progressive gait disturbance and leg weakness. His mother follows a strict vegan diet and breastfed him until age 2 without any supplements. Examination shows hypotonia, diminished deep tendon reflexes, and loss of vibration sense in lower extremities. MRI shows T2 hyperintensity in posterior columns of the spinal cord. Laboratory studies show MCV 108 fL and methylmalonic acid elevated. Apply the most appropriate initial treatment.
Q10
A 6-month-old exclusively breastfed infant presents with irritability and poor weight gain. Physical examination reveals pallor, tachycardia, and a systolic ejection murmur. Laboratory studies show hemoglobin 8.2 g/dL, MCV 68 fL, and ferritin 6 ng/mL. The mother reports exclusively breastfeeding without iron supplementation. Apply appropriate management for this condition.
Nutritional requirements and disorders US Medical PG Practice Questions and MCQs
Question 1: A 6-year-old with short bowel syndrome (40 cm remaining small bowel) on home parenteral nutrition for 4 years presents with progressive visual impairment and ataxia. Ophthalmologic exam shows retinopathy and ophthalmoplegia. Laboratory studies show vitamin E 2.1 mg/L (normal 5-18), normal vitamin A and D levels, PT/INR normal, and lipid profile shows total cholesterol 85 mg/dL. The family reports excellent compliance with prescribed fat-soluble vitamin supplementation in the parenteral formula. Synthesize the most likely explanation for isolated vitamin E deficiency.
A. Occult vitamin K deficiency depleting vitamin E through oxidative stress
B. Malabsorption from residual small bowel despite parenteral nutrition
C. Genetic defect in alpha-tocopherol transfer protein independent of nutritional status
D. Inadequate vitamin E supplementation dose in parenteral nutrition formula
E. Hypocholesterolemia impairing vitamin E transport via lipoproteins (Correct Answer)
Explanation: ***Hypocholesterolemia impairing vitamin E transport via lipoproteins***
- **Vitamin E** is unique among fat-soluble vitamins because it relies heavily on **lipoproteins** (VLDL, LDL, and HDL) for transport in the circulation.
- Significant **hypocholesterolemia** (Total Cholesterol 85 mg/dL), often seen in chronic parenteral nutrition, reduces the carrying capacity for **alpha-tocopherol**, leading to low serum levels despite adequate intake.
*Occult vitamin K deficiency depleting vitamin E through oxidative stress*
- The **PT/INR is normal**, which directly contradicts a diagnosis of significant **vitamin K deficiency**.
- There is no clinical or biochemical evidence that **oxidative stress** from low vitamin K specifically depletes vitamin E levels to this degree.
*Malabsorption from residual small bowel despite parenteral nutrition*
- **Parenteral nutrition** bypasses the gastrointestinal tract; therefore, **malabsorption** from the short bowel cannot explain a deficiency of vitamins delivered intravenously.
- This mechanism would typically affect all fat-soluble vitamins equivalently if the patient were relying on enteral intake, which is not the case here.
*Genetic defect in alpha-tocopherol transfer protein independent of nutritional status*
- While **Ataxia with Vitamin E Deficiency (AVED)** presents similarly, it is a rare autosomal recessive disorder usually diagnosed in the context of normal lipid levels.
- Given the patient's history of **short bowel syndrome** and known **hypocholesterolemia**, the transport defect is secondary to the low carrier proteins rather than a primary genetic mutation.
*Inadequate vitamin E supplementation dose in parenteral nutrition formula*
- The family reports **excellent compliance** with prescribed vitamins, and standard parenteral doses are usually sufficient to prevent deficiency in most patients.
- If the dose were simply too low, we might expect subtle deficiencies in other **fat-soluble vitamins** (A, D, K), which were all reported as normal in this patient.
Question 2: A 15-month-old presents with severe protein-energy malnutrition, hepatomegaly, edema, and skin changes (hypopigmentation with desquamation). Total protein 3.8 g/dL, albumin 1.9 g/dL, prealbumin 8 mg/dL. The parents want rapid nutritional rehabilitation, but the physician is concerned about complications. The child also has watery diarrhea and suspected concurrent infection. Evaluate the optimal initial refeeding strategy considering all risk factors.
A. Gradual refeeding starting at 60-80 kcal/kg/day with electrolyte monitoring and infection treatment (Correct Answer)
B. Total parenteral nutrition to bypass intestinal dysfunction
C. Immediate albumin infusion followed by standard nutritional rehabilitation
D. High-protein formula at 150% RDA to rapidly correct hypoalbuminemia
E. Standard infant formula at full caloric needs with multivitamin supplementation
Explanation: ***Gradual refeeding starting at 60-80 kcal/kg/day with electrolyte monitoring and infection treatment***
- Initial management of **Kwashiorkor** (edematous malnutrition) requires a cautious start at **lower caloric density** to prevent **Refeeding Syndrome**, characterized by fatal shifts in phosphorus, potassium, and magnesium.
- Concurrent treatment of **infections** and correction of **electrolyte imbalances** are critical prior to aggressive weight gain phases to reduce mortality in severe acute malnutrition.
*Total parenteral nutrition to bypass intestinal dysfunction*
- **TPN** is generally avoided in severe malnutrition due to the high risk of **sepsis**, metabolic derangement, and the fact that the **enteral route** helps maintain the intestinal mucosal barrier.
- **Enteral feeding** is preferred as it is safer and encourages the recovery of **atrophic intestinal villi** more effectively than parenteral routes.
*Immediate albumin infusion followed by standard nutritional rehabilitation*
- While **hypoalbuminemia** is present, **albumin infusions** are not indicated for correcting nutritional status and can lead to **volume overload** and cardiac failure in these fragile patients.
- Nutritional rehabilitation focuses on **endogenous protein synthesis** through gradual caloric and protein intake rather than exogenous replacement.
*High-protein formula at 150% RDA to rapidly correct hypoalbuminemia*
- Rapid introduction of **high protein** can overwhelm the liver's urea cycle and the kidneys, leading to **hyperammonemia** and metabolic decompensation.
- Rapid refeeding also triggers massive **insulin release**, which drives electrolytes into cells, worsening clinical instability.
*Standard infant formula at full caloric needs with multivitamin supplementation*
- Providing **full caloric needs** (>100 kcal/kg/day) at the onset of treatment can induce heart failure and **sudden death** due to the metabolic stress of refeeding.
- **Standard infant formula** may contain higher levels of **lactose** or **sodium** than can be tolerated by a child with severe mucosal atrophy and potential cardiac dysfunction.
Question 3: A 14-year-old girl with anorexia nervosa is admitted for refeeding. Her BMI is 13.5 kg/m². Initial laboratory studies show sodium 136 mEq/L, potassium 3.3 mEq/L, phosphorus 3.8 mg/dL, magnesium 1.9 mg/dL. On day 3 of refeeding (advancing from 800 to 1400 kcal/day), she develops confusion, weakness, and respiratory distress. Repeat labs show phosphorus 1.1 mg/dL, potassium 2.8 mEq/L, and magnesium 1.2 mg/dL. ECG shows QTc prolongation. Evaluate the pathophysiology and priority management.
A. Acute heart failure from volume overload during refeeding
B. Sepsis from bacterial translocation due to intestinal atrophy
C. Hypoglycemia from impaired gluconeogenesis and glycogen depletion
D. Rapid carbohydrate refeeding causing insulin surge and intracellular electrolyte shifts (Correct Answer)
E. Thiamine deficiency causing Wernicke encephalopathy with cardiac dysfunction
Explanation: ***Rapid carbohydrate refeeding causing insulin surge and intracellular electrolyte shifts***
- Nutritional intake after prolonged starvation triggers a massive **insulin surge**, shifting phosphate, potassium, and magnesium from the extracellular space into the cells.
- Severe **hypophosphatemia** is the hallmark, leading to a deficit in **ATP production**, which manifests as respiratory muscle weakness, cardiac dysfunction, and neurological confusion.
*Acute heart failure from volume overload during refeeding*
- While congestive heart failure can occur during refeeding because the **atrophied myocardium** cannot handle increased volume, it is typically secondary to the electrolyte shifts.
- The primary laboratory indicator for this patient's clinical deterioration is the profound **hypophosphatemia (1.1 mg/dL)** rather than simple fluid overload.
*Sepsis from bacterial translocation due to intestinal atrophy*
- Intestinal atrophy in anorexia can lead to translocation, but the timeline and **electrolyte triad** (low P, K, and Mg) are specifically diagnostic of **Refeeding Syndrome**.
- This patient lacks classic sepsis markers such as **fever** or leukocytosis, and the ECG changes point toward electrolyte disturbances.
*Hypoglycemia from impaired gluconeogenesis and glycogen depletion*
- Although malnourished patients have low **glycogen stores**, the introduction of 1400 kcal/day is more likely to cause hyperglycemia or metabolic stress rather than acute hypoglycemia.
- Hypoglycemia does not explain the dramatic drop in **phosphorus** and magnesium levels seen on day 3.
*Thiamine deficiency causing Wernicke encephalopathy with cardiac dysfunction*
- **Thiamine (Vitamin B1)** deficiency can cause Wet Beriberi or Wernicke’s, but it does not account for the severe **multivalent cation and anion depletion**.
- While thiamine should be supplemented, the **QTc prolongation** and respiratory distress are most directly tied to the life-threatening electrolyte shifts of Refeeding Syndrome.
Question 4: A 7-month-old infant presents with developmental regression, irritability, and poor feeding. He was born to consanguineous parents and has been on a special metabolic formula since birth due to an inborn error of metabolism. Examination shows hypotonia, megaloblastic anemia (MCV 115 fL), and homocystinuria without methylmalonic aciduria. Plasma homocysteine is markedly elevated while methionine is low. Analyze the most likely enzymatic defect.
A. Methylmalonyl-CoA mutase deficiency
B. Methylene tetrahydrofolate reductase deficiency
C. Cobalamin C deficiency
D. Cystathionine beta-synthase deficiency
E. Methionine synthase deficiency (Correct Answer)
Explanation: ***Methionine synthase deficiency***
- This condition results in **homocystinuria** and **low methionine** because the enzyme cannot convert homocysteine back to methionine using methyl-B12.
- The trapped folate in the **methyl-trap** state leads to impaired DNA synthesis, manifesting as **megaloblastic anemia** without methylmalonic aciduria.
*Methylmalonyl-CoA mutase deficiency*
- This defect leads to isolated **methylmalonic aciduria**, which presents with metabolic acidosis and hyperammonemia.
- It does not cause **megaloblastic anemia** or homocystinuria, contradicting the laboratory findings in this patient.
*Methylene tetrahydrofolate reductase deficiency*
- MTHFR deficiency causes **homocystinuria** and low methionine, but it typically lacks the associated **megaloblastic anemia**.
- The enzyme provides the substrate for methionine synthase but does not directly involve the **cobalamin** pathways associated with macrocytosis.
*Cobalamin C deficiency*
- This is a defect in intracellular cobalamin metabolism that usually causes both **homocystinuria and methylmalonic aciduria**.
- While it presents with developmental delay and **megaloblastic anemia**, the absence of methylmalonic acid in this case excludes this combined defect.
*Cystathionine beta-synthase deficiency*
- Classic homocystinuria due to CBS deficiency presents with **elevated methionine** levels due to the metabolic block in the transsulfuration pathway.
- It is not associated with **megaloblastic anemia**, as the folate/B12 remethylation pathway remains intact.
Question 5: A 2-year-old girl presents with bowing of legs, rachitic rosary, and delayed dentition. Radiographs show metaphyseal widening and cupping. Laboratory studies reveal calcium 8.5 mg/dL, phosphorus 2.1 mg/dL, PTH 95 pg/mL, alkaline phosphatase 850 U/L, and 25-hydroxyvitamin D 8 ng/mL. Her 4-year-old sibling has similar findings but with normal 25-hydroxyvitamin D levels and elevated 1,25-dihydroxyvitamin D. Analyze the most likely diagnosis in the sibling.
A. Vitamin D-dependent rickets type 2 (Correct Answer)
B. X-linked hypophosphatemic rickets
C. Chronic kidney disease-mineral bone disorder
D. Nutritional rickets with delayed presentation
E. Vitamin D-dependent rickets type 1
Explanation: ***Vitamin D-dependent rickets type 2***
- This condition, also known as **hereditary vitamin D-resistant rickets**, is caused by a mutation in the **vitamin D receptor (VDR)**, leading to end-organ resistance.
- The hallmark laboratory finding is **elevated 1,25-dihydroxyvitamin D** levels due to lack of feedback inhibition and compensatory increases in PTH.
*X-linked hypophosphatemic rickets*
- Characterized by **renal phosphate wasting** due to mutations in the **PHEX gene**, leading to increased **FGF23** levels.
- Unlike the sibling in this case, patients with XLH typically have **low or inappropriately normal 1,25-dihydroxyvitamin D** levels and normal PTH.
*Chronic kidney disease-mineral bone disorder*
- Occurs due to the kidney's inability to convert 25-hydroxyvitamin D to its active form, leading to **low 1,25-dihydroxyvitamin D**.
- It is associated with **elevated creatinine/BUN** and hyperphosphatemia, which are not described in the sibling.
*Nutritional rickets with delayed presentation*
- Caused by dietary deficiency or lack of sunlight, characterized by **low 25-hydroxyvitamin D** levels as seen in the index case girl.
- The sibling has **normal 25-hydroxyvitamin D**, which explicitly excludes simple nutritional deficiency as the primary cause.
*Vitamin D-dependent rickets type 1*
- Caused by a deficiency in the **1-alpha-hydroxylase** enzyme, which converts 25-OH vitamin D to its active 1,25-(OH)2 form.
- Laboratory studies would reveal **low levels of 1,25-dihydroxyvitamin D**, which contradicts the elevated levels seen in the sibling.
Question 6: A 5-year-old boy presents with night blindness and multiple respiratory infections over the past 6 months. He has a history of chronic pancreatitis secondary to cystic fibrosis. Physical examination reveals conjunctival xerosis and Bitot spots. Serum retinol level is 15 μg/dL (normal 30-80). Despite adequate pancreatic enzyme replacement, symptoms persist. Analyze the underlying mechanism and most likely additional deficiency.
A. Inadequate retinol-binding protein synthesis from protein malnutrition
B. Competitive inhibition of vitamin A absorption by vitamin E
C. Primary retinal dysfunction independent of nutritional status
D. Impaired conversion of beta-carotene to retinol due to zinc deficiency (Correct Answer)
E. Decreased bile acid secretion affecting fat-soluble vitamin absorption
Explanation: ***Impaired conversion of beta-carotene to retinol due to zinc deficiency***
- In patients with **cystic fibrosis**, chronic malabsorption leads to **zinc deficiency**, which is essential for the function of enzymes that convert **beta-carotene** to **retinol**.
- **Zinc** is also required for the synthesis of **retinol-binding protein (RBP)** and the mobilization of **Vitamin A** from the liver, making its deficiency a primary cause of persistent symptoms despite enzyme therapy.
*Inadequate retinol-binding protein synthesis from protein malnutrition*
- While **protein malnutrition** can decrease **RBP** levels, the clinical context of **cystic fibrosis** specifically points towards mineral and fat-soluble vitamin malabsorption.
- The patient's history of respiratory infections and **pancreatitis** suggests a more complex malabsorptive process than simple caloric **protein deficiency**.
*Competitive inhibition of vitamin A absorption by vitamin E*
- High doses of **vitamin E** can interfere with the absorption of other fat-soluble vitamins, but it does not cause **night blindness** in a patient with multi-system symptoms of **vitamin A deficiency**.
- This mechanism is rarely clinically significant compared to the direct **malabsorption** seen in **pancreatic insufficiency**.
*Primary retinal dysfunction independent of nutritional status*
- This patient's low **serum retinol** (15 μg/dL) and improvement in the context of the history confirm a **nutritional deficiency** rather than a genetic retinal dystrophy like **retinitis pigmentosa**.
- The presence of **Bitot spots** and **conjunctival xerosis** are hallmark physical signs of **Vitamin A deficiency**, not primary retinal disease.
*Decreased bile acid secretion affecting fat-soluble vitamin absorption*
- While **bile acid** issues can occur in liver disease, the primary driver here is **pancreatic insufficiency** leading to impaired **micelle formation**.
- Since the patient is already receiving **pancreatic enzyme replacement**, the persistence of symptoms indicates a specific metabolic hurdle, such as **zinc deficiency**, rather than a lack of bile.
Question 7: A 9-month-old infant presents with failure to thrive, chronic diarrhea, and a periorificial dermatitis. The mother reports the infant has been on a strict elimination diet due to suspected food allergies. Physical examination reveals alopecia, angular cheilitis, and vesiculobullous rash around the mouth, genitals, and extremities. Serum zinc level is 35 μg/dL (normal 60-120). Apply the appropriate management.
A. Oral zinc sulfate supplementation (Correct Answer)
B. Intravenous immunoglobulin therapy
C. Elimination of additional food allergens
D. Topical corticosteroids for dermatitis
E. Broad-spectrum antibiotic therapy
Explanation: ***Oral zinc sulfate supplementation***
- The patient presents with the classic triad of **acrodermatitis enteropathica**: **periorificial/acral dermatitis**, **alopecia**, and **diarrhea**, confirmed by a low **serum zinc level**.
- Elemental zinc at **1-2 mg/kg/day** typically results in rapid clinical improvement, often showing resolution of the rash within days of starting therapy.
*Intravenous immunoglobulin therapy*
- This is primarily used for **primary immunodeficiencies** or auto-immune conditions like **Kawasaki disease**.
- It does not address the nutritional deficiency of **zinc** which is the underlying cause of this infant's symptoms.
*Elimination of additional food allergens*
- Further restrictive dieting is contraindicated, as it was likely the catalyst for the **acquired zinc deficiency** through inadequate intake.
- Proper management involves expanding the diet and providing **nutritional counseling** to ensure all micronutrient requirements are met.
*Topical corticosteroids for dermatitis*
- While they might provide minimal symptomatic relief, they do not treat the root cause, and the rash of **zinc deficiency** is typically resistant to topical steroids.
- Over-reliance on steroids can lead to local side effects without correcting the **failure to thrive** or systemic symptoms like **diarrhea**.
*Broad-spectrum antibiotic therapy*
- This would be used if there was evidence of a primary **bacterial infection** or sepsis, which is not indicated by the clinical picture.
- Although **perioral rashes** can sometimes have secondary infections (like Candida or Staph), the primary management remains **zinc replacement**.
Question 8: A 4-month-old infant presents with tetany and seizures. Parents report exclusive breastfeeding with recent switch to homemade formula made from evaporated milk. Physical examination shows hyperreflexia and positive Chvostek sign. Laboratory studies reveal calcium 6.8 mg/dL, phosphorus 8.2 mg/dL, and PTH 180 pg/mL. ECG shows prolonged QT interval. Apply the immediate management.
A. Intravenous calcium gluconate infusion (Correct Answer)
B. Intramuscular vitamin D injection
C. Switch to commercial infant formula only
D. Oral calcium carbonate supplementation
E. Oral phosphate binders and calcium
Explanation: ***Intravenous calcium gluconate infusion***
- The infant is presenting with **symptomatic hypocalcemia**, evidenced by **tetany, seizures**, and a **prolonged QT interval**, which constitutes a medical emergency.
- Immediate stabilization requires **intravenous calcium gluconate** to elevate serum ionized calcium levels and prevent life-threatening **cardiac arrhythmias** or further seizure activity.
*Intramuscular vitamin D injection*
- While vitamin D deficiency may be a contributing factor, clinical stabilization of **acute neuromuscular irritability** must precede long-term nutritional replacement.
- Vitamin D takes days to effectively raise **calcium levels**, making it inappropriate for the management of an **acute seizure** or tetany.
*Switch to commercial infant formula only*
- Although shifting from high-phosphate evaporated milk to standard formula is necessary for long-term management of **infantile hypocalcemia**, it does not address the **acute emergency**.
- Dietary modification is a secondary step that follows the correction of **ionic imbalances** and stabilization of the patient.
*Oral calcium carbonate supplementation*
- Oral supplementation is insufficient for patients presenting with **seizures** or **Chvostek sign**, as the rate of absorption is too slow to provide immediate relief.
- Oral routes are contraindicated during **active seizures** due to the high risk of **aspiration** and the need for rapid metabolic correction.
*Oral phosphate binders and calcium*
- Phosphate binders are used in chronic management of **hyperphosphatemia**, but they play no role in the **emergency response** to low serum calcium levels.
- The primary goal in this acute setting is bypassing the gut to reverse **hypocalcemic tetany** via the **parenteral route**.
Question 9: A 3-year-old boy presents with progressive gait disturbance and leg weakness. His mother follows a strict vegan diet and breastfed him until age 2 without any supplements. Examination shows hypotonia, diminished deep tendon reflexes, and loss of vibration sense in lower extremities. MRI shows T2 hyperintensity in posterior columns of the spinal cord. Laboratory studies show MCV 108 fL and methylmalonic acid elevated. Apply the most appropriate initial treatment.
A. Intramuscular cyanocobalamin injections (Correct Answer)
B. Oral pyridoxine supplementation
C. Intravenous thiamine administration
D. Oral folic acid supplementation
E. Oral ferrous sulfate with ascorbic acid
Explanation: ***Intramuscular cyanocobalamin injections***
- The patient presents with **Subacute Combined Degeneration** of the spinal cord due to **Vitamin B12 deficiency**, confirmed by **elevated methylmalonic acid** and **macrocytic anemia**.
- **Intramuscular injections** are required as the initial treatment for symptomatic neurological involvement to ensure rapid absorption and bypass potential malabsorption, preventing permanent damage.
*Oral pyridoxine supplementation*
- **Vitamin B6 (Pyridoxine)** deficiency typically causes **sideroblastic anemia**, **seizures**, or peripheral neuropathy, but not posterior column degeneration.
- It does not cause an elevation in **methylmalonic acid**, which is highly specific for Vitamin B12 deficiency.
*Intravenous thiamine administration*
- **Thiamine (Vitamin B1) deficiency** leads to **Wernicke-Korsakoff syndrome** (ataxia, ophthalmoplegia, confusion) or **Beri-beri**, not macrocytic anemia.
- Thiamine deficiency does not present with **dorsal column T2 hyperintensity** on MRI or elevated methylmalonic acid levels.
*Oral folic acid supplementation*
- While **folate deficiency** causes macrocytic anemia, it does **not** cause neurological symptoms or an increase in **methylmalonic acid** levels.
- Treating Vitamin B12 deficiency with folate alone can improve the hematologic profile while **exacerbating the neurological symptoms**.
*Oral ferrous sulfate with ascorbic acid*
- This is the treatment for **Iron Deficiency Anemia**, which presents with **microcytic anemia** (low MCV) rather than macrocytic anemia.
- Iron deficiency does not cause **posterior column loss** or the specific metabolic elevations seen in this patient's lab results.
Question 10: A 6-month-old exclusively breastfed infant presents with irritability and poor weight gain. Physical examination reveals pallor, tachycardia, and a systolic ejection murmur. Laboratory studies show hemoglobin 8.2 g/dL, MCV 68 fL, and ferritin 6 ng/mL. The mother reports exclusively breastfeeding without iron supplementation. Apply appropriate management for this condition.
A. Immediate packed red blood cell transfusion
B. Start oral iron supplementation and continue breastfeeding (Correct Answer)
C. Switch to iron-fortified formula exclusively
D. Start iron supplementation and add vitamin C-rich foods
E. Continue exclusive breastfeeding and reassess in 2 months
Explanation: ***Start oral iron supplementation and continue breastfeeding***
- The infant displays **microcytic anemia** (low MCV) and low **ferritin**, diagnostic of **Iron Deficiency Anemia (IDA)** likely due to exclusive breastfeeding beyond 4 months without supplementation.
- **Oral elemental iron** at 3-6 mg/kg/day is the first-line treatment, and breastfeeding should be encouraged to continue for its nutritional and immunological benefits.
*Immediate packed red blood cell transfusion*
- Transfusion is generally reserved for patients with **hemodynamic instability** or severe anemia, usually defined by a **hemoglobin <7 g/dL**.
- This infant is stable despite the murmur and tachycardia, which are physiological compensations for chronic anemia, not signs of heart failure.
*Switch to iron-fortified formula exclusively*
- While iron-fortified formula is an option for feeding, it is unnecessary to discontinue **breastfeeding** to treat IDA.
- Breastfeeding provides optimal nutrition and antibodies; adding **medicinal iron** is the preferred strategy to correct the deficit.
*Start iron supplementation and add vitamin C-rich foods*
- Although **Vitamin C** enhances iron absorption, 6-month-old infants are just starting solids and should not rely on diet alone to correct a significant deficiency.
- Management must focus primarily on the **therapeutic dose of iron** rather than dietary tweaks which are insufficient for moderate anemia.
*Continue exclusive breastfeeding and reassess in 2 months*
- Delaying treatment is inappropriate as IDA can lead to **neurodevelopmental delays** and worsening fatigue or failure to thrive.
- At 6 months, an infant's **prenatal iron stores** are depleted, so intervention is required immediately upon diagnosis.
